retatrutide efficacy clinical trials The Effect of on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity New Phase 3 retatrutide data

Sources Mehrtash, F., Dushay, J., & Manson, J

Diabetes, 73(1), 3850

Next Steps Building on these results, Aon is continuing to track GLP-1 utilization, pricing and outcomes as new indications, products and financing models emerge

Det kan vara frustrerande att kmpa med att kontrollera aptiten eller att se att vikten inte rr sig som man skulle vilja

Results A total of 11 studies were included in this meta-analysis, including 6 studies on GLP-1 RA, 1 study on GLP-1 and GIP dual receptor agonists, 1 study on orlistat, 2 studies on phentermine-topiramate, and 1 study on naltrexone-bupropion (Additional file 1: Table S2) [22,23,24,25,26,27,28,29,30,31,32]